Palo Alto Investors LP Long-Term Concentrated

CIK: 0001306923 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 14, 2023

Total Value ($000): $1,172,888 (100.0% shares, 0.0% debt)

Holdings (29)

BMRN BIOMARIN PHARMACEUTICAL INC 16.6%
Value ($000) $195,163 Shares 1,885,811 Est. Cost $83.16 Unrealized +12.9%
UTHR UNITED THERAPEUTICS CORP 14.8%
Value ($000) $173,921 Shares 625,414 Est. Cost $89.23 Unrealized +182.9%
FOLD AMICUS THERAPEUTICS INC 10.9%
Value ($000) $128,128 Shares 10,493,722 Est. Cost $9.63 Unrealized +17.0%
INSM INSMED INC 10.0%
Value ($000) $117,308 Shares 5,871,291 Est. Cost $17.79 Unrealized +8.6%
BIIB BIOGEN INC 9.0%
Value ($000) $105,252 Shares 380,082 Est. Cost $264.98 Unrealized +6.6%
PRTA PROTHENA CORP PLC 8.5%
Value ($000) $99,929 Shares 1,658,577 Est. Cost $21.46 Unrealized +172.9%
REVANCE THERAPEUTICS INC 8.3%
Value ($000) $97,535 Shares 5,283,609 Est. Cost $21.40 Unrealized
STAA STAAR SURGICAL CO 5.1%
Value ($000) $60,193 Shares 1,240,077 Est. Cost $19.87 Unrealized +215.7%
ACAD ACADIA PHARMACEUTICALS INC 3.2%
Value ($000) $37,832 Shares 2,376,369 Est. Cost $28.53 Unrealized -45.2%
SAGE THERAPEUTICS INC 2.8%
Value ($000) $32,668 Shares 856,517 Est. Cost $46.62 Unrealized
KARYOPHARM THERAPEUTICS INC 1.6%
Value ($000) $19,229 Shares 5,655,676 Est. Cost $16.36 Unrealized
ALKS ALKERMES PLC 1.3%
Value ($000) $15,767 Shares 603,400 Est. Cost $22.36 Unrealized +7.0%
ALGN ALIGN TECHNOLOGY INC 1.3%
Value ($000) $15,734 Shares 74,605 Est. Cost $149.18 Unrealized +34.2%
SNDX SYNDAX PHARMACEUTICALS INC 1.3%
Value ($000) $15,591 Shares 612,600 Est. Cost $16.84 Unrealized +38.5%
ANAB ANAPTYSBIO INC 1.1%
Value ($000) $13,357 Shares 431,024 Est. Cost $19.06 Unrealized +48.2%
EHTH EHEALTH INC 1.0%
Value ($000) $12,025 Shares 2,484,479 Est. Cost $41.23 Unrealized -91.0%
VNDA VANDA PHARMACEUTICALS INC 0.7%
Value ($000) $8,037 Shares 1,087,607 Est. Cost $11.21 Unrealized -13.2%
CYTK CYTOKINETICS INC 0.4%
Value ($000) $5,119 Shares 111,717 Est. Cost $6.71 Unrealized +539.8%
KEZAR LIFE SCIENCES INC 0.4%
Value ($000) $4,620 Shares 656,200 Est. Cost $5.16 Unrealized
PROVENTION BIO INC 0.4%
Value ($000) $4,131 Shares 390,800 Est. Cost $4.50 Unrealized
TVTX TRAVERE THERAPEUTICS INC 0.3%
Value ($000) $3,492 Shares 166,069 Est. Cost $23.56 Unrealized -10.0%
GRITSTONE ONCOLOGY INC 0.2%
Value ($000) $2,298 Shares 666,127 Est. Cost $9.42 Unrealized
PEAK BIO INC 0.2%
Value ($000) $2,022 Shares 497,528 Est. Cost $4.06 Unrealized
MIRM MIRUM PHARMACEUTICALS INC 0.1%
Value ($000) $1,262 Shares 64,700 Est. Cost $15.56 Unrealized +27.1%
ALDX ALDEYRA THERAPEUTICS INC 0.1%
Value ($000) $1,119 Shares 160,800 Est. Cost $7.10 Unrealized -19.4%
ALIMERA SCIENCES INC 0.0%
Value ($000) $544 Shares 200,919 Est. Cost $6.30 Unrealized
TCMD TACTILE SYSTEMS TECHNOLOGY I 0.0%
Value ($000) $311 Shares 27,100 Est. Cost $39.74 Unrealized -77.9%
URGN UROGEN PHARMA LTD 0.0%
Value ($000) $217 Shares 24,500 Est. Cost $27.01 Unrealized -64.9%
GOSS GOSSAMER BIO INC 0.0%
Value ($000) $82 Shares 37,750 Est. Cost $11.85 Unrealized -30.5%